Skip to main content
logo
Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.5804
-0.0216 (-3.59%)
Sep 4, 2026, 2:31 PM EDT - Market open

Citius Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Operating Income
-57.37-38.53-42-36.73-33.32-23.53
Net Income
-46.27-37.43-40.19-33.69-33.64-24.51
Earnings Per Share
-2.12-3.38-5.97-5.57-5.76-5.64
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash & Investments
17.014.253.2526.4841.7170.07
Total Debt
7.181.810.260.480.680.86
Net Cash (Debt)
9.832.442.992641.0369.22
Net Cash Growth
133.64%-18.40%-88.50%-36.64%-40.72%453.40%
Net Cash Per Share
0.450.220.444.307.0215.93

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Operating Cash Flow
-34.87-26.55-28.2-29.06-28.36-24.25
Capital Expenditures
------0.01
Free Cash Flow
-34.87-26.55-28.2-29.06-28.36-24.26
Free Cash Flow Growth
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Forward PE
-1.378.717.117.117.88